CARGO Therapeutics Statistics

Total Valuation

CRGX has a market cap or net worth of $204.28 million. The enterprise value is -$99.32 million.

Market Cap	204.28M
Enterprise Value	-99.32M

Important Dates

The next estimated earnings date is Monday, August 11, 2025, before market open.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

CRGX has 46.11 million shares outstanding. The number of shares has increased by 191.07% in one year.

Current Share Class	46.11M
Shares Outstanding	46.11M
Shares Change (YoY)	+191.07%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	0.27%
Owned by Institutions (%)	58.70%
Float	24.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.71
P/TBV Ratio	0.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.30, with a Debt / Equity ratio of 0.11.

Current Ratio	6.30
Quick Ratio	6.21
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -65.94% and return on invested capital (ROIC) is -33.02%.

Return on Equity (ROE)	-65.94%
Return on Assets (ROA)	-30.07%
Return on Invested Capital (ROIC)	-33.02%
Return on Capital Employed (ROCE)	-60.79%
Revenue Per Employee	n/a
Profits Per Employee	-$1.29M
Employee Count	167
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-73.86%
50-Day Moving Average	4.31
200-Day Moving Average	11.24
Relative Strength Index (RSI)	50.18
Average Volume (20 Days)	677,420

Short Selling Information

The latest short interest is 2.34 million, so 5.08% of the outstanding shares have been sold short.

Short Interest	2.34M
Short Previous Month	2.60M
Short % of Shares Out	5.08%
Short % of Float	9.49%
Short Ratio (days to cover)	3.95

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-188.71M
Pretax Income	n/a
Net Income	-216.19M
EBITDA	-185.93M
EBIT	-188.71M
Earnings Per Share (EPS)	-$4.63

Full Income Statement

Balance Sheet

The company has $318.84 million in cash and $30.45 million in debt, giving a net cash position of $300.83 million or $6.52 per share.

Cash & Cash Equivalents	318.84M
Total Debt	30.45M
Net Cash	300.83M
Net Cash Per Share	$6.52
Equity (Book Value)	282.46M
Book Value Per Share	6.13
Working Capital	273.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$147.29 million and capital expenditures -$3.54 million, giving a free cash flow of -$150.83 million.

Operating Cash Flow	-147.29M
Capital Expenditures	-3.54M
Free Cash Flow	-150.83M
FCF Per Share	-$3.27

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRGX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-191.07%
Shareholder Yield	-191.07%
Earnings Yield	-107.28%
FCF Yield	-74.85%

Analyst Forecast

The average price target for CRGX is $4.67, which is 5.42% higher than the current price. The consensus rating is "Hold".

Price Target	$4.67
Price Target Difference	5.42%
Analyst Consensus	Hold
Analyst Count	7
Revenue Growth Forecast (5Y)	9.61%
EPS Growth Forecast (5Y)	-6.89%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1